Catherine A Fromen

Dr. Catherine A Fromen

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
BJBader M. Jarai
Bader M. Jarai
ZSZachary Stillman
Zachary Stillman
LALucas Attia
Lucas Attia
GDGerald E. Decker
Gerald E. Decker
EBEric D. Bloch
Eric D. Bloch
CFCatherine A Fromen
Catherine A Fromen

1 April 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
CFCatherine A Fromen
Catherine A Fromen
TRTojan B. Rahhal
Tojan B. Rahhal
GRGregory R. Robbins
Gregory R. Robbins
MKMarc P. Kai
Marc P. Kai
TSTammy W. Shen
Tammy W. Shen
JDJoseph M. DeSimone
Joseph M. DeSimone

29 December 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CFCatherine A Fromen
Catherine A Fromen
GRGregory R. Robbins
Gregory R. Robbins
TSTammy W. Shen
Tammy W. Shen
MKMarc P. Kai
Marc P. Kai
JTJenny P. Y. Ting
Jenny P. Y. Ting
JDJoseph M. DeSimone
Joseph M. DeSimone
Pulmonary immunization enhances local humoral and cell-mediated mucosal protection, which are critical for vaccination against lung-specific pathogens such as influenza or tuberculosis. A variety of nanoparticle (NP) formulations have been tested preclinically for pulmonary vaccine development, yet the role of NP surface charge on downstream immune responses remains poorly understood. We used the Particle Replication in Non-Wetting Templates (PRINT) process to synthesize hydrogel NPs that varied only in surface charge and otherwise maintained constant size, shape, and antigen loading. Pulmonary immunization with ovalbumin (OVA)-conjugated cationic NPs led to enhanced systemic and lung antibody titers compared with anionic NPs. Increased antibody production correlated with robust germinal center B-cell expansion and increased activated CD4+ T-cell populations in lung draining lymph nodes. Ex vivo treatment of dendritic cells (DCs) with OVA-conjugated cationic NPs induced robust antigen-specific T-cell proliferation with ∼100-fold more potency than soluble OVA alone. Enhanced T-cell expansion correlated with increased expression of surface MHCII, T-cell coactivating receptors, and key cytokines/chemokine expression by DCs treated with cationic NPs, which were not observed with anionic NPs or soluble OVA. Together, these studies highlight the importance of NP surface charge when designing pulmonary vaccines, and our findings support the notion that cationic NP platforms engender potent humoral and mucosal immune responses.

19 October 2017 in ACS Nano
Verified
Journal Article
Closed access
CFCatherine A Fromen
Catherine A Fromen
WKWilliam J. Kelley
William J. Kelley
MFMargaret B. Fish
Margaret B. Fish
RAReheman Adili
Reheman Adili
JNJeffery Noble
Jeffery Noble
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

23 October 2019 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
ZSZachary Stillman
Zachary Stillman
BJBader M. Jarai
Bader M. Jarai
NRNisha Raman
Nisha Raman
PPPremal Patel
Premal Patel
CFCatherine A Fromen
Catherine A Fromen
Hydrogel nanoparticles (also known as nanogels) have been utilized for a wide range of applications including analytics, sensors, drug delivery, immune engineering, and biotechnology. While these types of nanoparticles can be characterized using standard colloidal characterization techniques, degradation profiles typically must be inferred from those of bulk gels with the same formulation, typically by applying swelling ratios and rheological measurements that tend to severely underestimate nanoparticle degradation rates. Herein, we present an analysis of the degradation via ester hydrolysis of poly(ethylene glycol)diacrylate (PEGDA)-based hydrogel nanoparticles in water, varied pH conditions, and reducing environments. We perform this characterization using thermogravimetric analysis and mass spectrometry to analyze rates of degradation and products released, respectively, and compare results to those for equivalent bulk gel formulations. Our findings show that PEGDA-based nanoparticles display significant mass loss over time accompanied by negligible changes in hydrodynamic diameter, indicating a bulk mode of degradation. Nanoparticle mass loss occurs at a much higher rate than for bulk gels under comparable incubation conditions, confirming that bulk gel degradation serves as a poor surrogate for nanoparticle degradation. We further demonstrate that the incorporation of other diacrylate-based co-monomers drastically accelerates nanoparticle degradation rates. Through formulation considerations of co-monomer content and weight percent of PEGDA, we demonstrate the ability to tune the degradation rates of PEGDA-based nanoparticles on a range of hours to weeks. These findings highlight critical design considerations for enhancing the tunability and utility of PEGDA hydrogel nanoparticles and introduce a rigorous framework for the characterization of nanogel degradation.

10 June 2019 in Chemistry of Materials
Verified
Journal Article
Closed access
GDGerald E. Decker
Gerald E. Decker
ZSZachary Stillman
Zachary Stillman
LALucas Attia
Lucas Attia
CFCatherine A Fromen
Catherine A Fromen
EBEric D. Bloch
Eric D. Bloch